Announce Exclusive Supply And Distribution Agreement With Handok For Pivlaz In South Korea
15/04/2024 24:32
April 15 (Reuters) - Handok Inc 002390.KS :
* NXERA PHARMA CO LTD: ANNOUNCE EXCLUSIVE SUPPLY AND
DISTRIBUTION
AGREEMENT WITH HANDOK FOR PIVLAZ IN SOUTH KOREA
Source text for Eikon: ID:nTSpn8b338
Further company coverage: 002390.KS
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up